Brian Markison

Brian Markison

Former Chief Executive OfficeratLantheus Holdings· In proxies 2023–2025

Pay in FY2025+4% from the year before · Lantheus Holdings stock -25.6% the same year

Brian Markison was paid $13.9M in FY2025 (Dec), up 4%. Lantheus Holdings stock fell 25.6% that year.

Pay$100 in the stock at the end of FY23 → $107
Pay is from the Summary Compensation Table of each Lantheus Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lantheus HoldingsPublic company · 3 yr
    • Former Chief Executive Officer2023 – Present · 3 yrStock in role +104%
  2. RVL PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  3. Alere, IncPublic company
    • Director? – PresentNo stock prices for these years
  4. Cosette PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  5. ImmunomedicsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?